Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Preclinical toxicity results are consistent with the safety profile reported in the ongoing phase I clinical trial of NXP800 in patients with advanced ovarian cancer (NCT05226507), where treatment-related adverse events were mostly grade 12 gastrointestinal and metabolic (mainly nausea and vomiting), while increases in AST and ALT were rare and low-grade [37]
Tout fait
an irritability subscale of the Aberrant Behavior Checklist (ABC)(Norris et al., 2019)) improved significantly following increased levels of cysteine (a GSH precursor), leading to an increased GSH plasma concentration(Hardan et al., 2012)
Furthermore, the inclusion of 10 mg of Vitamin B6 as Pyridoxal-5-Phosphate (P-5-P) provides the critical spark for this entire metabolic engine
Free Radic Biol Med 29: 7178
Q-1069-056
